Señales en vivo de HRMY | Maximiza tus Ganancias con Getagraph.com

VENDER 106514 min ago

@ $32.54

Emitido: 13 feb 2024 @ 15:42

Retorno: -9.88%

Señal anterior: feb 12 - 14:47

Señal anterior: Comprar

Retorno: -6.62 %

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 16:00):

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States...

Stats
Volumen de hoy	368 849
Volumen promedio	373 238
Capitalización de mercado	1.66B
EPS	$0 ( 2024-02-22 )
Próxima fecha de ganancias	( $0.640 ) 2024-04-30
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	13.77
ATR14	$0.0290 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-29	Kapadia Sandip	Buy	15 000	Common Stock
2024-03-29	Kapadia Sandip	Sell	15 000	Restricted Stock Units
2024-03-29	Kapadia Sandip	Sell	8 013	Common Stock
2024-03-15	Dierks Jeffrey	Buy	11 979	Common Stock
2024-03-15	Dierks Jeffrey	Sell	9 644	Stock Option

INSIDER POWER
18.46
Last 99 transactions
Buy: 1 264 876 \| Sell: 2 130 732

Volumen Correlación

Largo: -0.14 (neutral)

Corto: 0.27 (neutral)

Signal:(47.646) Neutral

Harmony Biosciences Correlación

10 Correlaciones Más Positivas
NTCT	0.911
VIEW	0.911
RPRX	0.908
ALRS	0.906
RBB	0.896
ORRF	0.885
RPTX	0.881
BMRA	0.879
INCR	0.877
AYTU	0.877

10 Correlaciones Más Negativas
CVT	-0.916
CIFR	-0.904
COUP	-0.896
ACCD	-0.896
CRVL	-0.89
RAM	-0.889
CMPO	-0.889
CLBT	-0.888
DUOL	-0.886
DFH	-0.885

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Harmony Biosciences Correlación - Moneda/Commodity

0.43
( neutral )

0.38
( neutral )

0.00
( neutral )

0.41
( neutral )

0.20
( neutral )

0.00
( neutral )

Harmony Biosciences Finanzas

Annual	2023
Ingresos:	$582.02M
Beneficio Bruto:	$460.79M (79.17 %)
EPS:	$2.17

FY	2023
Ingresos:	$582.02M
Beneficio Bruto:	$460.79M (79.17 %)
EPS:	$2.17

FY	2022
Ingresos:	$437.86M
Beneficio Bruto:	$354.37M (80.93 %)
EPS:	$3.07

FY	2021
Ingresos:	$305.44M
Beneficio Bruto:	$249.92M (81.82 %)
EPS:	$0.697

Financial Reports:

No articles found.

Harmony Biosciences

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

Actualizaciones en tiempo real para Harmony Biosciences [HRMY]

Upcoming Earnings Alert